Hikma Pharmaceuticals PLC.

In News

Hikma Pharmaceuticals PLC stock (GB00B128J450): Is its generic drug focus strong enough to unlock ne - AD HOC NEWS

AD HOC NEWS - Apr 28, 2026

Hikma Pharmaceuticals gains amid takeover speculation - MSN

MSN - Apr 26, 2026

Hikma Pharmaceuticals advances Thursday, outperforms market - MarketWatch

MarketWatch - Apr 23, 2026

Hikma Pharmaceuticals Reiterates 2026 Guidance, Exits 503B Compounding in April Trading Update Call - Yahoo Finance

Yahoo Finance - Apr 24, 2026

Hikma Pharmaceuticals reiterates full-year guidance - Investing.com

Investing.com - Apr 23, 2026

ZAWYA: Hikma reiterates full year 2026 guidance following encouraging start to the year - TradingView

TradingView - Apr 24, 2026

Hikma Pharmaceuticals PLC Approves Final Cash Dividend, Payable on 30 April 2026 - marketscreener.com

marketscreener.com - Apr 23, 2026

Hikma Pharmaceuticals USA announces $1 Billion of new US investment to further expand its domestic manufacturing and development of essential generic medicines - PR Newswire

PR Newswire - Jun 28, 2025

Hikma Pharma tumbles on softer guidance as buyback fails to soften pill - Proactive financial news

Proactive financial news - Feb 26, 2026

Hikma Tells Justices Cox Ruling Boosts 'Skinny Label' Case - Law360

Law360 - Apr 13, 2026

Hikma Pharmaceuticals Delivers 2025 Revenue Growth In Line With Guidance - DirectorsTalk Interviews

DirectorsTalk Interviews - Feb 26, 2026

Hikma Pharmaceuticals slips Wednesday, underperforms market - MarketWatch

MarketWatch - Apr 22, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment